Literature DB >> 29943151

Protective effect of isoliquiritigenin against cerebral injury in septic mice via attenuation of NF-κB.

Peng Zou1, Hong-Ming Ji2, Jian-Wei Zhao1, Xin-Min Ding1, Zi-Gang Zhen1, Xuan Zhang1, Xiao-Qi Nie1, Li-Xiong Xue3.   

Abstract

BACKGROUND: The study was conducted to scrutinize the outcome of isoliquiritigenin (ISL) against cerebral injury in septic mice.
METHODS: The sepsis was introduced using cecal ligation and puncture (CLP) method in experimental mice. The effect of ISL was quantified using the content of brain water and blood brain barrier (BBB) permeability. The effect on the levels of myeloperoxidase (MPO), superoxide dismutase (SOD), malondialdehyde (MDA) and glutathione (GSH) in brain homogenates was also determined. The effect of ISL on the levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in serum was also estimated. The levels of various inflammatory biomarkers (COX-2 and PGE2) were also studied. The expression of NF-κB signalling cascade and inducible nitric oxide synthase (iNOS) was estimated by Western blot.
RESULTS: Compared with CLP group, the brain water content was found to be reduced significantly together with the enhanced BBB integrity in ISL treated group. The level of MDA was reduced together with enhanced level of SOD and GSH in the ISL treated group. The levels of TNF-α, IL-1β, and IL-6 were also found to be modulated in ISL group. The level of COX-2 and PGE2 was reduced to near normal after ISL administration together with increase in the IκBα expression and reduction of p65 and p-p65 expression in a concentration-dependent manner. The expression of iNOS was also found to be reduced in ISL group.
CONCLUSION: These results demonstrate that ISL causes protection of CLP-induced sepsis in experimental mice via multiple pathways.

Entities:  

Keywords:  Cerebral injury; Isoliquiritigenin; NF-κB; Oxidative stress; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 29943151     DOI: 10.1007/s10787-018-0503-z

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  32 in total

Review 1.  Oxidative stress and gene expression in sepsis.

Authors:  J Macdonald; H F Galley; N R Webster
Journal:  Br J Anaesth       Date:  2003-02       Impact factor: 9.166

2.  Cardiac effects of isoliquiritigenin.

Authors:  J W Wegener; H Nawrath
Journal:  Eur J Pharmacol       Date:  1997-05-12       Impact factor: 4.432

Review 3.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

Review 4.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  Oxidative parameters differences during non-lethal and lethal sepsis development.

Authors:  Michael Andrades; Cristiane Ritter; José Cláudio F Moreira; Felipe Dal-Pizzol
Journal:  J Surg Res       Date:  2005-01-06       Impact factor: 2.192

6.  Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca Ski cells.

Authors:  Fabienne Hirchaud; François Hermetet; Mourboul Ablise; Sylvie Fauconnet; Dominique A Vuitton; Jean-Luc Prétet; Christiane Mougin
Journal:  Planta Med       Date:  2013-11-08       Impact factor: 3.352

7.  The neuropathology of septic shock.

Authors:  Tarek Sharshar; Djillali Annane; Geoffroy Lorin de la Grandmaison; Jean Philippe Brouland; Nicholas S Hopkinson; Gray Françoise
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

8.  Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra).

Authors:  Young-Won Chin; Hyun-Ah Jung; Yue Liu; Bao-Ning Su; John A Castoro; William J Keller; Michael A Pereira; A Douglas Kinghorn
Journal:  J Agric Food Chem       Date:  2007-05-22       Impact factor: 5.279

9.  Nuclear factor-kappaB and its role in sepsis-associated organ failure.

Authors:  Edward Abraham
Journal:  J Infect Dis       Date:  2003-06-15       Impact factor: 5.226

10.  Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages.

Authors:  S H Lee; J Y Kim; G S Seo; Y-C Kim; D H Sohn
Journal:  Inflamm Res       Date:  2009-05       Impact factor: 4.575

View more
  8 in total

1.  Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.

Authors:  Yasmine F Ibrahim; Rabab A Moussa; Asmaa M A Bayoumi; Al-Shaimaa F Ahmed
Journal:  Inflammopharmacology       Date:  2019-08-22       Impact factor: 4.473

2.  Neuroprotective and anti-inflammatory effects of isoliquiritigenin in kainic acid-induced epileptic rats via the TLR4/MYD88 signaling pathway.

Authors:  Xiaobo Zhu; Jiankun Liu; Ou Chen; Jiang Xue; Shanying Huang; Weiwei Zhu; Yibiao Wang
Journal:  Inflammopharmacology       Date:  2019-04-29       Impact factor: 4.473

3.  Isoliquiritigenin Provides Protection and Attenuates Oxidative Stress-Induced Injuries via the Nrf2-ARE Signaling Pathway After Traumatic Brain Injury.

Authors:  Man Zhang; Li-Li Huang; Chen-Huai Teng; Fang-Fang Wu; Li-Yun Ge; Yu-Juan Shi; Zheng-Le He; Lei Liu; Cheng-Jie Jiang; Ruo-Nan Hou; Jian Xiao; Hong-Yu Zhang; Da-Qing Chen
Journal:  Neurochem Res       Date:  2018-11-16       Impact factor: 3.996

4.  Down-regulating microRNA-20a regulates CDH1 to protect against cerebral ischemia/reperfusion injury in rats.

Authors:  Chun-Chun Yang; Xiang-Pin Wei; Xian-Ming Fu; Ling-Tao Qian; Lan-Jun Xie; Hong-Bo Liu; Gang Li; Xin-Gang Li; Xian-Wei Zeng
Journal:  Cell Cycle       Date:  2020-12-19       Impact factor: 4.534

5.  Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells.

Authors:  Manman Li; Guicong Lu; Xiao Ma; Ruihong Wang; Xihong Chen; Yongxiong Yu; Caode Jiang
Journal:  BMC Vet Res       Date:  2022-08-19       Impact factor: 2.792

6.  Protective effect of Secukinumab on severe sepsis model rats by neutralizing IL-17A to inhibit IKBα/NFκB inflammatory signal pathway.

Authors:  Guangsheng Gao; Yun Li; Xingsheng Wang; Xinxin Zhang; Li Sun
Journal:  Eur J Med Res       Date:  2022-10-17       Impact factor: 4.981

7.  Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity.

Authors:  Xiaobo Zhu; Jiankun Liu; Shaojie Chen; Jiang Xue; Shanying Huang; Yibiao Wang; Ou Chen
Journal:  BMC Neurosci       Date:  2019-08-06       Impact factor: 3.288

Review 8.  Novel Synthetic and Natural Therapies for Traumatic Brain Injury.

Authors:  Denise Battaglini; Dorota Siwicka-Gieroba; Patricia Rm Rocco; Fernanda Ferreira Cruz; Pedro Leme Silva; Wojciech Dabrowski; Iole Brunetti; Nicolò Patroniti; Paolo Pelosi; Chiara Robba
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.